MedTrace Logo

Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement

NCT05614986 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2026-01-27

No results posted yet for this study

Summary

This trail is for patients with mild cognitive impairment (MCI) who are receiving a transcatheter aortic valve replacement (TAVR). We will assess changes in neurocognition following TAVR with the 5 minute Montreal Cognitive Assessment (mini MoCA) when comparing pre procedure with post procedure assessments.

Conditions

Interventions

OTHER

5 minute Montreal Cognitive Assessment (mini MoCA)

The mini MoCA will be completed by the patient before TAVR, and 30 days and 6 months after TAVR

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Srinivasa Potluri, MD · Baylor Scott and White The Heart Hospital Plano

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-17
Primary Completion
2023-10-02
Completion
2024-02-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05614986 on ClinicalTrials.gov